WCN25-499 PATIENT BASELINE CHARACTERISTICS IN THE ONGOING PHASE 3 VISIONARY TRIAL: A RANDOMIZED, PLACEBO-CONTROLLED STUDY OF SIBEPRENLIMAB FOR IMMUNOGLOBULIN A NEPHROPATHY

WCN25-499 PATIENT BASELINE CHARACTERISTICS IN THE ONGOING PHASE 3 VISIONARY TRIAL: A RANDOMIZED, PLACEBO-CONTROLLED STUDY OF SIBEPRENLIMAB FOR IMMUNOGLOBULIN A NEPHROPATHY

Saved in:

Bibliographic Details
Main Authors:	Richard Lafayette, Hernan Trimarchi, Jonathan Barratt, Kevin Carroll, Vladimír Tesar, Hong Zhang, Yusuke Suzuki, Adrian Liew, Muh Geot Wong, Lokesh Shah, Jing Xia, Cecile Fajaro, Jeffrey Hafkin, Vlado Perkovic
Format:	Article
Language:	English
Published:	Elsevier 2025-02-01
Series:	Kidney International Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468024924023507
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

WCN24-1799 HEMATURIA RESOLUTION WITH THE APRIL-BLOCKING MONOCLONAL ANTIBODY, SIBEPRENLIMAB, IN PATIENTS WITH IgA NEPHROPATHY IN A PHASE 2 RANDOMIZED CONTROLLED TRIAL
by: Jonathan Barratt, et al.
Published: (2024-04-01)

WCN24-847 SPARSENTAN VS IRBESARTAN IN PATIENTS WITH IMMUNOGLOBULIN A NEPHROPATHY (IgAN): SUBGROUP ANALYSES OF 2-YEAR RESULTS FROM THE PIVOTAL PHASE 3 PROTECT TRIAL
by: Jonathan Barratt, et al.
Published: (2024-04-01)

Focal Segmental Glomerulosclerosis Patient Baseline Characteristics in the Sparsentan Phase 3 DUPLEX Study
by: Howard Trachtman, et al.
Published: (2024-04-01)

WCN25-1567 Glomerular disease registry and Biobank (GRIT)– design and baseline results
by: Sradha Kotwal, et al.
Published: (2025-02-01)

WCN24-1674 NEFECON TREATMENT RESPONSE IN ASIAN AND WHITE PATIENT POPULATIONS WITH IMMUNOGLOBULIN A NEPHROPATHY: A 2YEAR ANALYSIS OF THE PHASE III NEFIGARD TRIAL
by: Jonathan Barratt, et al.
Published: (2024-04-01)

More than spectators, visionaries
by: Laura Marcolini
Published: (2024-12-01)

Corticosteroid Effects in IgA Nephropathy by Baseline Proteinuria and Estimated GFR
by: Dana Kim, et al.
Published: (2025-06-01)

The large landowner as a visionary planner
by: Stéphane Sadoux
Published: (2022-11-01)

Study Design and Baseline Characteristics of ALIGN, a Randomized Controlled Study of Atrasentan in Patients With IgA Nephropathy
by: Hiddo J.L. Heerspink, et al.
Published: (2025-01-01)

WCN24-1001 EFFECT OF CORTICOSTEROIDS ON KIDNEY AND SAFETY OUTCOMES IN IGA NEPHROPATHY ACROSS DIFFERENT LEVELS OF PROTEINURIA AND EGFR: A POST HOC ANALYSIS OF THE TESTING STUDY
by: Muh Geot Wong, et al.
Published: (2024-04-01)

VISIONARY APPROACH TO THE DEVELOPMENT PROBLEMS OF RUSSIA AND THE WORLD
by: V. M. Bondarenko
Published: (2016-04-01)

Art for Necessity, Mediumnic Art, Visionaries and Spectators
by: Graciela García Muñoz
Published: (2008-10-01)

Andrew Lees, a visionary mentored by a madman
by: Francisco Cardoso

Corrigendum to “Study Design and Baseline Characteristics of ALIGN, a Randomized Controlled Study of Atrasentan in Patients With IgA Nephropathy” [Volume 10, Issue 1, January 2025, Pages 217-226]
by: Hiddo J.L. Heerspink, et al.
Published: (2025-04-01)

WCN24-1837 BEYOND: A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBOCONTROLLED TRIAL OF ZIGAKIBART IN ADULTS WITH IGA NEPHROPATHY
by: Hernán Trimarchi, et al.
Published: (2024-04-01)

Dr. B.B. Joshi - A visionary Hand Surgeon
by: Sandhya Kaushik
Published: (2011-05-01)

Dr. B.B. Joshi - A visionary Hand Surgeon
by: Sandhya Kaushik
Published: (2011-01-01)

Urban Market Metamorphosis: A visionary Design for Community Engagement
by: Mansi Yadav, et al.
Published: (2024-06-01)

Transforming Islamic Higher Education Institutions Through Visionary Leadership
by: Fridiyanto Fridiyanto, et al.
Published: (2025-07-01)

Visionary leadership and job crafting: a moderated mediation model
by: Mohammed Yasin Ghadi
Published: (2024-09-01)

Mary Seely, visionary scientist and dedicated teacher, turns 70
by: Viv Ward, et al.
Published: (2009-11-01)

The Efficacy and Safety of Reduced-Dose Oral Methylprednisolone in High-Risk Immunoglobulin A Nephropathy
by: Dana Kim, et al.
Published: (2024-07-01)

Effects of the Mediterranean Diet on Cardiovascular Outcomes-A Systematic Review and Meta-Analysis.
by: Thaminda Liyanage, et al.
Published: (2016-01-01)

A Satirist of the Present, Chronicler of our Exile and a Visionary of the Possible
by: Thabo Tšehloane
Published: (2025-08-01)

Remembering Prof. Girish Sahni: A Visionary Scientist and Pioneer in Biotechnology
by: Arunaloke Chakrabarti
Published: (2024-12-01)

The Tradition of Saint Patrick’s Purgatory between Visionary Literature and Pilgrimage Reports
by: Giovanni Paolo Maggioni
Published: (2017-12-01)

MicroRNA-499a in heart diseases: prospects for use in diagnostics. A review
by: Maria V. Pisklova, et al.
Published: (2025-01-01)

Sustainability Through Directed Change in the Visionary University: From Predicting to Producing the Future
by: Adrian Curaj, et al.
Published: (2020-08-01)

Designing a Human Resources Development Model with Visionary leadership Approach in Education
by: Mahdi Taghvaei, et al.
Published: (2024-06-01)

Can Reading the Life of a Self-Abusive Visionary Make Sense Today?
by: Mary Frohlich
Published: (2025-02-01)

David Stephen Calonne, Diane Di Prima: Visionary Poetics and the Hidden Religions
by: Erik Mortenson
Published: (2020-06-01)

Brian O’Connell (1947–2024): A visionary, inclusive and caring educationist
by: Ramashwar Bharuthram
Published: (2024-12-01)

Transformational, Visionary, and Prophetic Leadership: Their Impact on Teacher Job Satisfaction in Madrasa Ibtidaiyah
by: Juhji Juhji, et al.
Published: (2024-09-01)

Michael Robertson. The Last Utopians. Four Late Nineteenth-Century Visionaries and their Legacy
by: Christine Reynier
Published: (2019-06-01)

WCN24-2099 BASELINE CHARACTERISTICS OF THE ALIGN TRIAL: A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL TRIAL OF ATRASENTAN IN PATIENTS WITH IGAN
by: Hiddo J.L. Heerspink, et al.
Published: (2024-04-01)

Timothy Shenk, Realigners: Partisan Hacks, Political Visionaries, and the Struggle to Rule American Democracy
by: Léa Chevrollier
Published: (2023-06-01)

Visionary leadership: the mediating role of organizational support on nurse interns’ creativity and organizational effectiveness
by: Manal Saleh Moustafa Saleh, et al.
Published: (2025-04-01)

WCN24-1354 Worldwide Use of Sodium Glucose Co-transporter 2 Inhibitors in Immunoglobulin A nephropathy: A country and Regional Analysis
by: Chee Kay Cheung, et al.
Published: (2024-04-01)

P499: Incidental findings in rapid exome and genome testing in pediatric ICU: Clinical and psychological implications
by: Adnan Alsadah
Published: (2025-01-01)

WCN25-1572 DESIGN AND BASELINE CHARACTERISTICS OF THE GLOBAL KIDNEY PATIENT TRIALS NETWORK
by: Sradha Kotwal, et al.
Published: (2025-02-01)